» Articles » PMID: 9952045

Differential Effects of GABA(A) and GABA(B) Agonists on Sensitization to the Locomotor Stimulant Effects of Ethanol in DBA/2 J Mice

Overview
Specialty Pharmacology
Date 1999 Feb 10
PMID 9952045
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Contemporary theories of drug abuse suggest that behavioral sensitization plays an important role in addiction. However, few studies have examined the mechanisms underlying behavioral sensitization to ethanol. The present study examined the ability of THIP (2, 4, or 8 mg/kg) and baclofen (5.0, 6.25, or 7.5 mg/kg), GABA(A) and GABA(B) agonists, respectively, to prevent development of sensitization to the locomotor stimulant effects of ethanol (2 g/kg) in DBA/2 J mice. Ethanol was administered immediately before four 5-min activity trials conducted at 48-h intervals. Administration of ethanol on each of the four trials resulted in behavioral sensitization in control groups. While having few effects on activity when given alone, both GABA agonists completely blocked the acute stimulant response to ethanol on the first trial. Administration of THIP prior to ethanol on each trial failed to prevent development of sensitization. In contrast, all doses of baclofen blocked sensitization. Assessment of blood ethanol levels 15, 50 and 100 min after administration of ethanol indicated that baclofen did not change the pharmacokinetics of ethanol. These results indicate an important role for GABA(B) receptors, but not GABA(A) receptors, in development of sensitization to the locomotor stimulant effects of ethanol.

Citing Articles

Systemic administration of racemic baclofen reduces both acquisition and maintenance of alcohol consumption in male and female mice.

Bauer M, Hernandez M, Kasten C, Boehm 2nd S Alcohol. 2022; 103:25-35.

PMID: 35870740 PMC: 9835998. DOI: 10.1016/j.alcohol.2022.06.003.


Reducing effect of the novel positive allosteric modulator of the GABA receptor, COR659, on binge-like alcohol drinking in male mice and rats.

Lorrai I, Shankula C, Marquez Gaytan J, Kawamura T, Maccioni P, Mugnaini C Psychopharmacology (Berl). 2021; 239(1):201-213.

PMID: 34812900 DOI: 10.1007/s00213-021-06022-3.


Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder.

Augier E Alcohol Alcohol. 2021; 56(2):139-148.

PMID: 33561865 PMC: 7906877. DOI: 10.1093/alcalc/agab003.


Non-genetic factors that influence methamphetamine intake in a genetic model of differential methamphetamine consumption.

Stafford A, Reed C, Phillips T Psychopharmacology (Berl). 2020; 237(11):3315-3336.

PMID: 32833064 PMC: 7572688. DOI: 10.1007/s00213-020-05614-9.


GABA Receptors and Alcohol Use Disorders: Preclinical Studies.

Holtyn A, Weerts E Curr Top Behav Neurosci. 2020; 52:157-194.

PMID: 32808090 DOI: 10.1007/7854_2020_178.